Smoking and home oxygen therapy: a review and consensus statement from a multidisciplinary Swedish taskforce.
Journal
European respiratory review : an official journal of the European Respiratory Society
ISSN: 1600-0617
Titre abrégé: Eur Respir Rev
Pays: England
ID NLM: 9111391
Informations de publication
Date de publication:
31 Jan 2024
31 Jan 2024
Historique:
received:
28
09
2023
accepted:
02
12
2023
medline:
1
2
2024
pubmed:
1
2
2024
entrez:
31
1
2024
Statut:
epublish
Résumé
Home oxygen therapy (HOT) improves survival in patients with hypoxaemic chronic respiratory disease. Most patients evaluated for HOT are former or active smokers. Oxygen accelerates combustion and smoking may increase the risk of burn injuries and fire hazards; therefore, it is considered a contraindication for HOT in many countries. However, there is variability in the practices and policies regarding this matter. This multidisciplinary Swedish taskforce aimed to review the potential benefits and risks of smoking in relation to HOT, including medical, practical, legal and ethical considerations. The taskforce of the Swedish Respiratory Society comprises 15 members across respiratory medicine, nursing, medical law and ethics. HOT effectiveness and adverse risks related to smoking, as well as practical, legal and ethical considerations, were reviewed, resulting in five general questions and four PICO (population-intervention-comparator-outcome) questions. The strength of each recommendation was rated according to the GRADE (grading of recommendation assessment, development and evaluation) methodology. General questions about the practical, legal and ethical aspects of HOT were discussed and summarised in the document. The PICO questions resulted in recommendations about assessment, management and follow-up of smoking when considering HOT, if HOT should be offered to people that meet the eligibility criteria but who continue to smoke, if a specific length of time of smoking cessation should be considered before assessing eligibility for HOT, and identification of areas for further research. Multiple factors need to be considered in the benefit/risk evaluation of HOT in active smokers. A systematic approach is suggested to guide healthcare professionals in evaluating HOT in relation to smoking.
Sections du résumé
BACKGROUND
BACKGROUND
Home oxygen therapy (HOT) improves survival in patients with hypoxaemic chronic respiratory disease. Most patients evaluated for HOT are former or active smokers. Oxygen accelerates combustion and smoking may increase the risk of burn injuries and fire hazards; therefore, it is considered a contraindication for HOT in many countries. However, there is variability in the practices and policies regarding this matter. This multidisciplinary Swedish taskforce aimed to review the potential benefits and risks of smoking in relation to HOT, including medical, practical, legal and ethical considerations.
METHODS
METHODS
The taskforce of the Swedish Respiratory Society comprises 15 members across respiratory medicine, nursing, medical law and ethics. HOT effectiveness and adverse risks related to smoking, as well as practical, legal and ethical considerations, were reviewed, resulting in five general questions and four PICO (population-intervention-comparator-outcome) questions. The strength of each recommendation was rated according to the GRADE (grading of recommendation assessment, development and evaluation) methodology.
RESULTS
RESULTS
General questions about the practical, legal and ethical aspects of HOT were discussed and summarised in the document. The PICO questions resulted in recommendations about assessment, management and follow-up of smoking when considering HOT, if HOT should be offered to people that meet the eligibility criteria but who continue to smoke, if a specific length of time of smoking cessation should be considered before assessing eligibility for HOT, and identification of areas for further research.
CONCLUSIONS
CONCLUSIONS
Multiple factors need to be considered in the benefit/risk evaluation of HOT in active smokers. A systematic approach is suggested to guide healthcare professionals in evaluating HOT in relation to smoking.
Identifiants
pubmed: 38296345
pii: 33/171/230194
doi: 10.1183/16000617.0194-2023
pmc: PMC10828833
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright ©The authors 2024.
Déclaration de conflit d'intérêts
Conflict of interest: The authors have no conflict of interest relevant for this study to declare.
Références
Am Rev Respir Dis. 1982 May;125(5):507-10
pubmed: 7081807
Anesth Analg. 1986 Nov;65(11):1186-8
pubmed: 3767017
Tob Control. 2018 Sep;27(5):568-576
pubmed: 29170168
N Engl J Med. 2020 Sep 17;383(12):1129-1138
pubmed: 32937046
Eur Respir J. 1999 Nov;14(5):1002-8
pubmed: 10596681
Ann Intern Med. 2005 Feb 15;142(4):233-9
pubmed: 15710956
Lancet. 1981 Mar 28;1(8222):681-6
pubmed: 6110912
Ann Am Thorac Soc. 2023 Nov;20(11):1587-1594
pubmed: 37413976
Respir Med. 2006 Feb;100(2):218-25
pubmed: 15932796
Lancet Respir Med. 2023 May;11(5):402-405
pubmed: 36966792
Am Rev Respir Dis. 1992 May;145(5):1070-6
pubmed: 1586049
Am J Respir Crit Care Med. 2020 Nov 15;202(10):e121-e141
pubmed: 33185464
J Am Coll Surg. 2014 Jun;218(6):1182-6
pubmed: 24698489
Respirology. 2016 Jan;21(1):76-8
pubmed: 26599614
Can Respir J. 2015 Mar-Apr;22(2):83-5
pubmed: 25848719
J Burn Care Res. 2022 Sep 1;43(5):1024-1031
pubmed: 35815812
J Med Ethics. 2006 May;32(5):263-5
pubmed: 16648275
Ann Intern Med. 1980 Sep;93(3):391-8
pubmed: 6776858
Respiration. 2017;93(4):253-263
pubmed: 28142139
Eur Respir J. 2017 May 25;49(5):
pubmed: 28546272
Int J Chron Obstruct Pulmon Dis. 2017 Jan 05;12:193-197
pubmed: 28123292
Ann Am Thorac Soc. 2022 Oct;19(10):1677-1686
pubmed: 35657698
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Eur Respir J. 1995 Aug;8(8):1398-420
pubmed: 7489808
J Pain Symptom Manage. 2013 Mar;45(3):517-23
pubmed: 22921175
Eur Respir J. 2021 Oct 7;58(4):
pubmed: 33653807
Transplantation. 2012 Nov 27;94(10):979-87
pubmed: 23169222
J Burn Care Res. 2023 Mar 2;44(2):249-253
pubmed: 36734524
PLoS One. 2011;6(12):e28864
pubmed: 22194931
Am J Respir Crit Care Med. 2003 Nov 1;168(9):1034-42
pubmed: 12869359
Respir Res. 2014 Mar 13;15:30
pubmed: 24625018
Addiction. 2004 Jan;99(1):29-38
pubmed: 14678060
Arch Intern Med. 1982 Mar;142(3):473-8
pubmed: 7065785
Thorax. 1997 Dec;52 Suppl 5:S1-28
pubmed: 9474238
Int J Chron Obstruct Pulmon Dis. 2017 Oct 30;12:3159-3169
pubmed: 29133978
Eur Respir J. 1988 Dec;1(10):952-8
pubmed: 3224692
Med J Aust. 1998 Jan 5;168(1):21-5
pubmed: 9451391
Ann Am Thorac Soc. 2023 Jul;20(7):1070-1073
pubmed: 37083544
Int J Chron Obstruct Pulmon Dis. 2015 Nov 13;10:2479-84
pubmed: 26622175
N Engl J Med. 2016 Oct 27;375(17):1617-1627
pubmed: 27783918
Cochrane Database Syst Rev. 2016 Nov 25;11:CD006429
pubmed: 27886372
Lancet Respir Med. 2018 Oct;6(10):759-770
pubmed: 30170904
Am J Respir Crit Care Med. 2018 May 15;197(10):1254-1264
pubmed: 29547003
Am J Respir Crit Care Med. 2015 Jul 15;192(2):e3-19
pubmed: 26177183
Cochrane Database Syst Rev. 2016 Jul 06;7:CD011716
pubmed: 27383922
Lancet. 2010 Sep 4;376(9743):784-93
pubmed: 20816546
J Bras Pneumol. 2010 May-Jun;36(3):332-8
pubmed: 20625671
Thorax. 2015 Jun;70 Suppl 1:i1-43
pubmed: 25870317
Ann Am Thorac Soc. 2018 Dec;15(12):1369-1381
pubmed: 30499721
J Burn Care Res. 2016 Jan-Feb;37(1):25-31
pubmed: 26284642
Am J Prev Med. 2008 Aug;35(2):158-76
pubmed: 18617085
Breathe (Sheff). 2015 Mar;11(1):4-12
pubmed: 26306099